A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune) Meeting Abstract

  

Authors:	McKay, R. R.; Liu, L.; Pu, M.; Araneta, A.; Yuen, K. L.; Gomez, J.; Castano, N.; Ajmera, A.; Ye, H.; Pili, R.; Runcie, K.; McHugh, D. J.; Offit, K.; Paller, C. J.; Haas, N. B.; Javier-Desloges, J.; Kane, C. J.; Seibert, T. M.; Bagrodia, A.
Abstract Title:	A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
Meeting Title:	2024 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	16 Suppl.
Meeting Dates:	2024 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-06-01
Language:	English
ACCESSION:	WOS:001275557406256
PROVIDER:	wos
DOI:	10.1200/JCO.2024.42.16_suppl.TPS5128
Notes:	Meeting Abstract: TPS5128 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/218858